During the post implant period, recent studies have shown an improvement of parental behavior as well as the development of the child in the domains of shared

attention, problem solving, symbolic play and social functioning. In addition, during this stage the relationships between parents and children are more effective, and all parental figures are positively motivated towards appropriate behaviors. Hence the effects of CI are no longer limited to the implanted child, but now entail the entire family. In fact, the parents judge the quality of their lives on the basis of how successful they perceive the results obtained by having their child undergo a CI. Consequently, they regulate their behavior and attitudes influencing the child’s development. Parents themselves AZD9291 order maintain that specialized psychological support is fundamental during

all stages connected to CI and more Selleck AZD7762 generally to the overall development of their child.”
“Background Patients with functional chest pain (FCP) represent a therapeutic challenge for practising physicians.\n\nAim To determine the efficacy of Johrei as compared to wait-list in improving symptoms of FCP patients.\n\nMethods Patients with chest pain of noncardiac origin for at least 3 months were enrolled into the study. All patients had to have negative upper endoscopy, pH testing and oesophageal manometry prior to randomization. Subsequently, patients were randomized to either Johrei or wait-list control. Patients received 18 Johrei sessions from a Johrei practitioner for 6 weeks.\n\nResults A total of 21 FCP patients enrolled into the Johrei group and 18 into the wait-list group. There was no difference in symptom intensity score between Johrei group and wait-list group at baseline (20.28 vs. 23.06, Momelotinib supplier P = N. S.). However, there

was a significant pre- and post-treatment reduction in symptom intensity in the Johrei group (20.28 vs. 7.0, P = 0.0023). There was no significant reduction in symptom intensity score between baseline and at the end of the study in the wait-list group (23.06 vs. 20.69, P = N. S.).\n\nConclusion This pilot study shows that Johrei may have a role in improving FCP symptoms; however, future studies are needed to compare Johrei treatment with sham Johrei or supportive care.”
“A 10-year-old child presented after accidental exposure of the left eye to a blue hair dye containing methylene blue. Mild ocular surface changes and a selective blue staining of the usually invisible corneal nerve fibre bundles were present. Corneal sensitivity was reduced. Despite copious lubrication a transient neurotrophic keratitis developed which did not resolve until corneal sensitivity became normal 2 weeks later. Association of mild chemical burns with neurotrophic keratitis is unusual but is of high clinical relevance as keratitis is a vision-threatening complication.